Flt-1 expression influences apoptotic susceptibility of vascular smooth muscle cells through the NF-κB/IAP-1 pathway

Cardiovascular Research

Volumn 85, Issue 1, 2010, Pages 214-223

  Orlandi, Augusto ^a   Ferlosio, Amedeo ^a   Arcuri, Gaetano ^a   Scioli, Maria Giovanna ^a   De Falco, Sandro ^b   Spagnoli, Luigi Giusto ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

Author keywords

Apoptosis; Flt 1; IAP 1; NF B; Vascular remodelling

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; MESSENGER RNA; PLACENTAL GROWTH FACTOR; PROTEIN BAX; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INTIMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; RNA INTERFERENCE; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ADULT; AGED; ANIMALS; APOPTOSIS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PREGNANCY PROTEINS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 72049121930     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp288     Document Type: Article

References (46)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
2. Clowes A, Reidy M, Clowes M. Mechanisms of stenosis after arterial injury. Lab Invest 1983;49:208-215.
3. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 1995;95:2266-2274.
4. Bochaton-Piallat ML, Gabbiani F, Redard M, Desmouliere A, Gabbiani G. Apopto-sis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol 1995;146:1059-1064.
5. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 1983; 49:327-333.
6. Orlandi A, Ehrlich HP, Ropraz P, Spagnoli LG, Gabbiani G. Rat aortic smooth muscle cells isolated from different layers and at different times after endothelial denudation show distinct biological features in vitro. Arterioscler Thromb 1994;14: 982-989.
7. Perlman H, Maillard L, Krasinski K, Walsh K. Evidence for the rapid onset of apop-tosis in medial smooth muscle cells after balloon injury. Circulation 1997;95: 981-987.
8. Walker LN, Bowen-Pope DF, Ross R, Reidy MA. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci USA 1986;83:7311-7315.
9. Orlandi A, Pucci S, Ciucci A, Pichiorri F, Ferlosio A, Spagnoli LG. Modulation of clusterin isoforms is associated with all-trans retinoic acid-induced proliferative arrest and apoptosis of intimal smooth muscle cells. Arterioscler Thromb Vasc Biol 2005;25:348-353.
10. Hao H, Gabbiani G, Bochaton-Piallat ML. Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol 2003;23:1510-1520.
11. Orlandi A, Francesconi A, Cocchia D, Corsini A, Spagnoli LG. Phenotypic heterogeneity influences apoptotic susceptibility to retinoic acid and cis-platinum of rat arterial smooth muscle cells in vitro: Implications for the evolution of experimental intimal thickening. Arterioscler Thromb Vasc Biol 2001;21:1118-1123.
12. Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R et al. Vascular endo-thelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998;98:2108-2116.
13. Reidy MA, Irvin C, Lindner V. Migration of arterial wall cells. Expression of plas-minogen activators and inhibitors in injured rat arteries. Circ Res 1996;78: 405-414.
14. Torsney E, Mandal K, Halliday A, Jahangiri M, Xu Q. Characterisation of progenitor cells in human atherosclerotic vessels. Atherosclerosis 2007;191:259-264.
15. Zhao Q, Egashira K, Hiasa K, Ishibashi M, Inoue S, Ohtani K et al. Essential role of vascular endothelial growth factor and Flt-1 signals in neointimal formation after periadventitial injury. Arterioscler Thromb Vasc Biol 2004;24:2284-2289.
16. De Falco S, Gigante B, Persico MG. Structure and function of placental growth factor. Trends Cardiovasc Med 2002;12:241-246.
17. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F et al. Revascular-ization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogen-esis, arthritis and atherosclerosis by anti-Flt1. Nat Med 2002;8:831-840.
18. Bentzon JF, Weile C, Sondergaard CS, Hindkjaer J, Kassem M, Falk E. Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. Arterioscler Thromb Vasc Biol 2006; 26:2696-2702.
19. Xu Q. Stem cells and transplant arteriosclerosis. Circ Res 2008;102:1011-1024.
20. Rodriguez-Menocal L, St-Pierre M, Wei Y, Khan S, Mateu D, Calfa M et al. The origin of post-injury neointimal cells in the rat balloon injury model. Cardiovasc Res 2009;81:46-53.
21. Couper LL, Bryant SR, Eldrup-Jorgensen J, Bredenberg CE, Lindner V. Vascular endothelial growth factor increases the mitogenic response to fibroblast growth factor-2 in vascular smooth muscle cells in vivo via expression of fms-like tyrosine kinase-1. Circ Res 1997;81:932-939.
22. Parenti A, Brogelli L, Filippi S, Donnini S, Ledda F. Effect of hypoxia and endo-thelial loss on vascular smooth muscle cell responsiveness to VEGF-A: role of flt-1/VEGF-receptor-1. Cardiovasc Res 2002;55:201-212.
23. Ohtani K, Egashira K, Hiasa K, Zhao Q, Kitamoto S, Ishibashi M et al. Blockade of vascular endothelial growth factor suppresses experimental restenosis after intra-luminal injury by inhibiting recruitment of monocyte lineage cells. Circulation 2004; 110:2444-2452.
24. Orlandi A, Di Lascio A, Francesconi A, Scioli MG, Arcuri G, Ferlosio A et al. Stem cell marker expression and proliferation and apoptosis of vascular smooth muscle cells. Cell Cycle 2008;7:3889-3897.
25. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275.
26. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 1997; 35:2-3.
27. Orlandi A, Francesconi A, Marcellini M, Di Lascio A, Spagnoli LG. Propionyl-L-carnitine reduces proliferation and potentiates Bax-related apoptosis of aortic intimal smooth muscle cells by modulating nuclear factor-kappaB activity. J Biol Chem 2007;282:4932-4942.
28. Orlandi A, Ferlosio A, Gabbiani G, Spagnoli LG, Ehrlich PH. Phenotypic heterogeneity influences the behavior of rat aortic smooth muscle cells in collagen lattice. Exp Cell Res 2005;311:317-327.
29. Bochaton-Piallat ML, Ropraz P, Gabbiani F, Gabbiani G. Phenotypic heterogeneity of rat arterial smooth muscle cell clones. Implications for the development of experimental intimal thickening. Arterioscler Thromb Vasc Biol 1996;16:815-820.
30. Frid MG, Aldashev AA, Nemenoff RA, Higashito R, Westcott JY, Stenmark KR. Subendothelial cells from normal bovine arteries exhibit autonomous growth and constitutively activated intracellular signaling. Arterioscler Thromb Vasc Biol 1999;19:2884-2893.
31. Shibata M, Suzuki H, Nakatani M, Koba S, Geshi E, Katagiri T et al. The involvement of vascular endothelial growth factor and flt-1 in the process of neointimal proliferation in pig coronary arteries following stent implantation. Histochem Cell Biol 2001;116:471-481.
32. Gigante B, Morlino G, Gentile MT, Persico MG, De Falco S. Plgf-/-eNos-/-mice show defective angiogenesis associated with increased oxidative stress in response to tissue ischemia. FASEB J 2006;20:970-972.
33. Ponticelli S, Marasco D, Tarallo V, Albuquerque RJ, Mitola S, Takeda A et al. Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1. J Biol Chem 2008;283:34250-34259.
34. Fischer C, Mazzone M, Jonckx B, Carmeliet P. FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer 2008;8:942-956.
35. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6: 389-395.
36. Schaper W, Scholz D. Factors regulating arteriogenesis. Arterioscler Thromb Vasc Biol 2003;23:1143-1151.
37. Carmeliet P. VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nat Med 2000;6:1102-1103.
38. Cai J, Ahmad S, Jiang WG, Huang J, Kontos CD, Boulton M et al. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells. Diabetes 2003;52:2959-2968.
39. Thanos D, Maniatis T. NF-kappa B: a lesson in family values. Cell 1995;80: 529-532.
40. Lindner V. The NF-kappaB and IkappaB system in injured arteries. Pathobiology 1998;66:311-320.
41. Bourcier T, Sukhova G, Libby P. The nuclear factor kappa-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J Biol Chem 1997;272:15817-15824.
42. Roy H, Bhardwaj S, Babu M, Kokina I, Uotila S, Ahtialansaari T et al. VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NF-kappaB, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits. FASEB J 2006;20:2159-2161.
43. Deveraux QL, Reed JC. IAP family proteins-suppressors of apoptosis. Genes Dev 1999;13:239-252.
44. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998;281:1680-1683.
45. Erl W, Hansson GK, de Martin R, Draude G, Weber KS, Weber C. Nuclear factor-kappa B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. Circ Res 1999;84: 668-677.
46. Toruner M, Fernandez-Zapico M, Sha JJ, Pham L, Urrutia R, Egan LJ. Antianoikis effect of nuclear factor-kappaB through up-regulated expression of osteoprote-gerin, BCL-2, and IAP-1. J Biol Chem 2006;281:8686-8696.